Alignment Healthcare ALHC Insider Ownership

NASDAQ ALHC

$8.44 -0.07 (-0.82%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

74.91Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

10.97%

▼-0.874% pp QoQ

Shares Held by Insiders

22.75Mn

filed for Sep 2026

▼-7.38% QoQ

Shares Outstanding

207.45Mn

207,448,894 shares

Direct Holdings

8.59Mn

Indirect: 14.16Mn

Net Shares Traded (QoQ)

-1.81Mn

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 16, 2026

Over the trailing 12 months, ALHC insiders bought $197,627 worth of shares (14.85K shares) and sold $314.6 million worth (17.06Mn shares) in open-market trades.

Behind Alignment Healthcare's open-market trades in the past 12 months were one insider buying and 10 insiders selling.
Among ALHC's insiders, Mark D. Kent (President & Mso) was the top open-market buyer in the past 12 months, with $197,627 of stock purchased (14.85K shares) and the latest purchase on June 2, 2026.
Conversely, General Atlantic, L.P. (10% owner) was ALHC's largest open-market seller in the past 12 months, with $206.49 million of sales (11.12Mn shares); the latest was on December 12, 2025.
Alignment Healthcare's latest insider trade on the open market was a sale of 32.48K shares for $269,576 by Hyong Kim (Chief Medical Officer) on October 6, 2026.
Beyond open-market trades, insiders at Alignment Healthcare received 1.2Mn shares in stock awards, acquired 152.07K shares through option exercises and conversions and gave away 25.7K shares as gifts in the last 12 months.
Business Quant data shows Alignment Healthcare insiders holding 22.71Mn shares in total in their latest Form 4 filings, or 10.95% of the 207.45Mn shares outstanding; that total is down 7.51% from 24.56Mn shares at the end of Q2 2026 and down 42.19% from 39.29Mn shares at the end of Q3 2025.
By type of ownership, ALHC insiders hold 37.66% of their shares directly (8.55Mn shares) and 62.34% indirectly (14.16Mn shares).
ALHC's insider total is spread across 22 insiders who have filed a Form 4 in the past two years.
ALHC's largest insider holders by reported holdings are General Atlantic (Aln HLTH), L.P. (10% owner, 13.48Mn shares), John E. Kao (Chief Executive Officer, 1.81Mn shares) and Robert Thomas Freeman (Chief Financial Officer, 1.56Mn shares).
Of the shares held by ALHC insiders, 59.33% belong to General Atlantic (Aln HLTH), L.P.
In the last 12 months, 81 Form 4 filings with transactions in ALHC stock came from 21 insiders.
These insider figures for Alignment Healthcare are based on Form 4 filings through October 7, 2026.

Form 4 Holdings

Insiders Holding ALHC

Insiders 32

Shares held 74.91Mn

Of outstanding 36.11%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Pincus Partners Gp Llc Warburg	Director, TenPercentOwner	0	17,922,779	17,922,779	23.9%	20 Sep, 2022
2	Pincus Llc Warburg	Director, TenPercentOwner	0	17,922,779	17,922,779	23.9%	20 Sep, 2022
3	Atlantic, L.P. General	TenPercentOwner	0	13,476,585	13,476,585	18.0%	12 Dec, 2025
4	Atlantic (Aln Hlth), L.P. General	TenPercentOwner	0	13,476,585	13,476,585	18.0%	12 Dec, 2025
5	Donald Steven Furman	Chief Clinical Officer	1,826,538	0	1,826,538	2.4%	01 Apr, 2022
6	Robert Thomas Freeman	Chief Financial Officer	1,464,419	0	1,464,419	2.0%	28 Mar, 2025
7	Dinesh M. Kumar	Chief Med Operating Officer	1,088,651	0	1,088,651	1.5%	31 Mar, 2023
8	Joseph S Konowiecki	Evp, Corporate Affairs	1,080,305	0	1,080,305	1.4%	18 Sep, 2026
9	Dawn Christine Maroney	President	794,606	0	794,606	1.1%	11 Sep, 2026
10	Hakan Kardes	Chief Experience Officer	678,987	0	678,987	0.9%	28 Mar, 2025
11	John E Kao	Chief Executive Officer	0	590,766	590,766	0.8%	16 Sep, 2026
12	Robert L. Scavo	Chief Information Officer	487,685	0	487,685	0.7%	19 Mar, 2026
13	Jeffrey H Margolis	Director	0	413,533	413,533	0.6%	16 Aug, 2024
14	Richard A. Cross	Svp, General Counsel	393,460	0	393,460	0.5%	31 Mar, 2023
15	Mark B. Mcclellan	Director	370,531	0	370,531	0.5%	17 Mar, 2026
16	Christopher J Joyce	Chief Legal And Admin. Officer	305,451	0	305,451	0.4%	01 Apr, 2026
17	Jacqueline B Kosecoff	Director	303,963	0	303,963	0.4%	17 Mar, 2026
18	Hyong Kim	Chief Medical Officer	299,271	0	299,271	0.4%	07 Oct, 2026
19	Sebastian Burzacchi	Coo Mgmt Services Org	258,630	0	258,630	0.3%	19 Mar, 2026
20	Melinda Michele Kimbro	Chief People Officer	175,439	0	175,439	0.2%	07 Jul, 2023
21	James M Head	Chief Financial Officer	173,495	0	173,495	0.2%	08 Apr, 2026
22	David C Hodgson	Director	173,408	0	173,408	0.2%	17 Mar, 2026
23	Nicholas Robbert Vorhoff	Director	173,408	0	173,408	0.2%	17 Mar, 2026
24	Rajesh Shrestha	Pres., New Markets Cbo	170,220	0	170,220	0.2%	01 Apr, 2022
25	Andreas P. Wagner	Chief Human Resources Officer	148,628	0	148,628	0.2%	19 Mar, 2026
26	Margaret M Mccarthy	Director	144,441	0	144,441	0.2%	17 Mar, 2026
27	Jody L Bilney	Director	129,267	0	129,267	0.2%	17 Mar, 2026
28	Thomas J. Carella	Director	124,478	0	124,478	0.2%	15 Mar, 2024
29	Yon Jorden	Director	105,830	0	105,830	0.1%	17 Mar, 2026
30	Mark D. Kent	President Mso	102,567	0	102,567	0.1%	09 Jun, 2026
31	Shane J. Hochradel	Chief Operations Officer	87,719	0	87,719	0.1%	02 Jul, 2026
32	Adnan R. Mansour	Chief Digital Officer	48,456	0	48,456	0.1%	17 Mar, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

560 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
06 Oct, 2026	Hyong Kim	Chief Medical Officer	Disposed S	32,479	$8.30	$269.58K	299,271	Direct
17 Sep, 2026	Joseph S Konowiecki	Evp, Corporate Affairs	Disposed S	23,511	$8.61	$202.43K	1,080,305	Direct
14 Sep, 2026	John E Kao	Chief Executive Officer	Disposed S	27,400	$13.00	$356.20K	590,766	Indirect
10 Sep, 2026	John E Kao	Chief Executive Officer	Disposed S	172,600	$12.96	$2.24Mn	618,166	Indirect
11 Sep, 2026	Dawn Christine Maroney	President	Disposed S	122,707	$12.68	$1.56Mn	794,606	Direct
11 Sep, 2026	John E Kao	Chief Executive Officer	Disposed S	385,270	$12.68	$4.89Mn	1,223,473	Direct
14 Aug, 2026	Dawn Christine Maroney	President	Disposed S	5,000	$14.00	$70.00K	917,313	Direct
10 Aug, 2026	John E Kao	Chief Executive Officer	Disposed S	298,000	$13.88	$4.14Mn	790,766	Indirect
15 Jul, 2026	Dawn Christine Maroney	President	Acquired M	152,068	$9.06	$1.38Mn	1,099,381	Direct
15 Jul, 2026	Dawn Christine Maroney	President	Disposed S	177,068	$20.83	$3.69Mn	922,313	Direct
15 Jul, 2026	Dawn Christine Maroney	President	Disposed M	152,068	$9.06	$1.38Mn	0	Direct
10 Jul, 2026	John E Kao	Chief Executive Officer	Disposed S	279,644	$19.81	$5.54Mn	1,107,122	Indirect
10 Jul, 2026	John E Kao	Chief Executive Officer	Disposed S	18,356	$20.65	$379.00K	1,088,766	Indirect
01 Jul, 2026	Shane J. Hochradel	Chief Operations Officer	Acquired A	87,719	$0.00	$0	87,719	Direct
01 Jul, 2026	Joseph S Konowiecki	Evp, Corporate Affairs	Disposed S	25,000	$24.00	$600.00K	1,103,816	Direct
26 Jun, 2026	Joseph S Konowiecki	Evp, Corporate Affairs	Disposed S	25,000	$23.00	$575.00K	1,128,816	Direct
18 Jun, 2026	Joseph S Konowiecki	Evp, Corporate Affairs	Disposed S	25,000	$22.00	$550.00K	1,153,816	Direct
15 Jun, 2026	Dawn Christine Maroney	President	Disposed S	30,000	$19.55	$586.43K	947,313	Direct
12 Jun, 2026	Hyong Kim	Chief Medical Officer	Disposed S	35,951	$19.86	$713.95K	331,750	Direct
10 Jun, 2026	John E Kao	Chief Executive Officer	Disposed S	74,936	$19.65	$1.47Mn	1,609,830	Indirect

Showing 1 to 20 of 560 transactions